Counterirritation by Menthol: Molecular Targets and Role in Airway Disease

薄荷醇的抗刺激作用：分子靶标及其在气道疾病中的作用

基本信息

批准号：
8022797
负责人：
SVEN-ERIC JORDT
金额：
$ 44.64万
依托单位：
YALE UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
起止时间：
2011-01-01 至 2014-12-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/8022797
关键词：
Acrolein Acute Address Affect Afferent Neurons Analgesics Asthma Behavioral Biochemical Biological Factors Breathing C Fiber Chemicals Chronic Chronic Obstructive Airway Disease Cigarette Cigarette smoke-induced emphysema Cotinine Coughing Disease Exposure to Food Gene Family Goals Government Hypertension Hypesthesia Image Individual Inflammation Inflammatory Inhalation Exposure Ion Channel Irritants Lung Inflammation Lung diseases Malignant neoplasm of lung Mediating Mentha piperita Menthol Minority Modeling Molecular Molecular Target Mouse Strains Mus Nerve Fibers Neurons Neuropeptides Nicotine Nicotine Dependence Nociception Outcome Pain Pharmaceutical Preparations Physiological Pneumonia Population Process Protein Isoforms Publishing Pulmonary Emphysema Receptor Signaling Research Respiratory System Role Sensory Serum Smoke Smoker Smoking Symptoms System TRPA1 Channel Terpenes Testing Therapeutic Time Tobacco Tobacco smoke Work afferent nerve base cigarette smoking insight irritation mouse model receptor research study respiratory respiratory reflex response smoke inhalation vapor

项目摘要

DESCRIPTION (provided by applicant): Menthol, the cooling terpene derived from peppermint, is widely used for the treatment of cough, respiratory irritation and pain. As a cigarette additive menthol is especially popular with beginning smokers and in minority populations disproportionally affected by COPD, lung cancer and hypertension. It is currently unclear whether menthol contributes to these disease conditions through inhibition of the respiratory irritation response mediated by chemosensory neurons. Recently, two sensory menthol receptors were identified: TRPM8, the cold/menthol receptor, and TRPA1, a reactive irritant receptor. TRPA1 is activated by acrolein and other irritants contained in tobacco smoke. Our preliminary studies show that inhalation of menthol potently inhibits the respiratory irritation response to acrolein vapor in mice. Mice inhaling smoke from mentholated cigarettes showed higher serum levels of the nicotine metabolite, cotinine, than mice exposed to non-mentholated smoke, suggesting increased exposure to nicotine. In electrophysiological and fluorescent imaging experiments we show that menthol inhibits acrolein-activated TRPA1 channels. We hypothesize that: 1.) Menthol acts as a counterirritant, blocking sensory neuronal responses to inhaled noxious chemicals through interaction with the menthol receptors TRPA1 or TRPM8, and 2) As a tobacco additive, menthol facilitates smoke inhalation through inhibition of neuronal irritant receptor signalling, thereby accelerating nicotine dependence and lung disease. The studies proposed in this application will use physiological, biochemical, molecular and behavioral approaches to: Aim 1.) Define the roles of TRPA1 and TRPM8 in menthol-induced inhibition of acute respiratory irritation. Aim 2.) Examine the pharmacological effects of menthol and menthol-related compounds on irritant-induced activation of sensory neurons. Aim 3.) Determine the effects of menthol inhalation on smoking-induced lung inflammation and emphysema. Our proposed research will provide new insights into neuronal mechanisms of airway irritation and remodeling, and define a scientific basis for regulatory efforts targeting menthol as a tobacco additive. PUBLIC HEALTH RELEVANCE: The natural product menthol is contained in medications against cold symptoms and pain, in food and in cigarettes. This application aims to reveal how menthol reduces irritation, and if menthol causes more severe smoking-related disease. Our work may aid the government in determining whether to regulate menthol as a cigarette additive, and may reveal new treatments for cough and pain.

描述（由申请人提供）：薄荷醇是从薄荷中提取的具有清凉作用的萜烯，广泛用于治疗咳嗽、呼吸道刺激和疼痛。作为一种卷烟添加剂，薄荷醇特别受初吸烟者和受慢性阻塞性肺病、肺癌和高血压影响的少数群体的欢迎。目前尚不清楚薄荷醇是否通过抑制化学感应神经元介导的呼吸道刺激反应而导致这些疾病。最近，鉴定了两种感觉薄荷醇受体：TRPM8（冷/薄荷醇受体）和 TRPA1（反应性刺激受体）。 TRPA1 被烟草烟雾中的丙烯醛和其他刺激物激活。我们的初步研究表明，吸入薄荷醇可有效抑制小鼠对丙烯醛蒸气的呼吸道刺激反应。吸入薄荷香烟烟雾的小鼠比接触非薄荷烟雾的小鼠表现出更高的尼古丁代谢物可替宁血清水平，这表明尼古丁接触量增加。在电生理学和荧光成像实验中，我们表明薄荷醇抑制丙烯醛激活的 TRPA1 通道。我们假设：1.) 薄荷醇充当反刺激剂，通过与薄荷醇受体 TRPA1 或 TRPM8 相互作用，阻断感觉神经元对吸入有毒化学物质的反应，2) 作为烟草添加剂，薄荷醇通过抑制神经元刺激受体信号传导促进烟雾吸入，从而加速尼古丁依赖和肺部疾病。本申请中提出的研究将使用生理、生化、分子和行为方法来：目标 1.) 定义 TRPA1 和 TRPM8 在薄荷醇诱导的急性呼吸道刺激抑制中的作用。目标 2.) 检查薄荷醇和薄荷醇相关化合物对刺激物诱导的感觉神经元激活的药理作用。目标 3.) 确定吸入薄荷醇对吸烟引起的肺部炎症和肺气肿的影响。我们提出的研究将为气道刺激和重塑的神经元机制提供新的见解，并为针对薄荷醇作为烟草添加剂的监管工作确定科学基础。公共健康相关性：天然产品薄荷醇存在于治疗感冒症状和疼痛的药物、食物和香烟中。该应用旨在揭示薄荷醇如何减少刺激，以及薄荷醇是否会导致更严重的与吸烟相关的疾病。我们的工作可能有助于政府决定是否将薄荷醇作为卷烟添加剂进行监管，并可能揭示治疗咳嗽和疼痛的新疗法。